Department of Rheumatology, Saga University Hospital, 5-1-1 Nabeshima, Saga, 849-8501, Japan.
Drugs Aging. 2024 Sep;41(9):713-724. doi: 10.1007/s40266-024-01137-6. Epub 2024 Aug 3.
Still's disease (SD) is a rare systemic inflammatory disease that is characterized by high fever, polyarthritis, and an evanescent rash as its main symptoms but that may also be complicated by pleuritis and macrophage activation syndrome (MAS). There has been a recent increase in studies on older-onset SD, which presents with less-typical clinical features, such as sore throat, skin lesions, and splenomegaly, but more complications including pleuritis and disseminated intravascular coagulation. Several reports have shown higher levels of inflammatory markers, including serum ferritin, and poorer outcomes in terms of survival and drug-free remission in older patients. In addition, caution is needed when diagnosing SD in older patients because of the increased incidence of differential diagnoses such as infectious diseases, malignancies, and inflammatory diseases. Prognosis is poor in older patients, and treatment-associated infections and severe complications such as MAS are the main cause of mortality. The use of biologics and treatment response may not differ greatly between older and younger patients. Although the data are limited, anti-IL-1 and anti-IL-6 agents may control SD in these patients with careful use and adequate infection prevention. Recent studies that classified adult-onset SD by cluster analysis or latent class analysis showed that older patients form a unique cluster of SD, indicating the need for clinicians to pay more attention to the diagnosis and management of SD in older patients.
斯蒂尔病(Still's disease,SD)是一种罕见的全身性炎症性疾病,以高热、多发性关节炎和一过性皮疹为主要症状,但也可能并发胸膜炎和巨噬细胞活化综合征(macrophage activation syndrome,MAS)。最近,关于老年发病 SD 的研究有所增加,其表现为不太典型的临床特征,如咽痛、皮疹和脾肿大,但并发症更多,包括胸膜炎和弥漫性血管内凝血。几项报告显示,老年患者的炎症标志物水平(包括血清铁蛋白)较高,生存和无药物缓解的结果较差。此外,由于老年患者鉴别诊断的发病率增加,如感染性疾病、恶性肿瘤和炎症性疾病,因此在诊断 SD 时需要谨慎。老年患者的预后较差,与治疗相关的感染和 MAS 等严重并发症是导致死亡的主要原因。生物制剂的使用和治疗反应在老年和年轻患者之间可能没有太大差异。尽管数据有限,但在谨慎使用和充分预防感染的情况下,抗 IL-1 和抗 IL-6 药物可能控制老年患者的 SD。最近通过聚类分析或潜在类别分析对成人发病 SD 进行分类的研究表明,老年患者形成了 SD 的独特亚群,这表明临床医生需要更加关注老年患者 SD 的诊断和管理。